ADVERTISEMENT
Aortic Frontiers, CREST-2, Optimal Duration of DAPT
02/03/2016
Gary Roubin leads the panel in discussing the bright future of new technologies in peripheral vascular disease. Details and goals of the CREST-2 Registry are outlined. Optimal patient selection and credentialing of operators in approved centers will be extremely important. Gus Pichard summarizes the IAGS consensus on guidelines for DAPT.
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement